The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

The Evolution and Prognostic Role of Tumour-Infiltrating Lymphocytes and Peripheral Blood-Based Biomarkers in Inflammatory Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

Introduction: Inflammatory breast cancer (IBC) is a rare but aggressive form of breast cancer (BC) in which the (prognostic) role of stromal tumour-infiltrating lymphocytes (sTIL) and the peripheral circulating immune cells in patients with residual disease (RD) after neo-adjuvant chemotherapy (NACT...

Full description

Bibliographic Details
Main Authors: Christophe Van Berckelaer, Iris Vermeiren, Leonie Vercauteren, Charlotte Rypens, Gizem Oner, Xuan Bich Trinh, Wiebren A. A. Tjalma, Glenn Broeckx, Emmanuelle Charafe-Jauffret, Steven Van Laere, François Bertucci, Cecile Colpaert, Peter A. van Dam
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
inflammatory breast cancer (IBC)
neo-adjuvant chemotherapy (NACT)
stromal tumour-infiltrating lymphocytes (sTIL)
immune response
lymphocyte-to-monocyte ratio (LMR)
neutrophil-to-lymphocyte ratio (NLR)
Online Access:https://www.mdpi.com/2072-6694/13/18/4656

Internet

https://www.mdpi.com/2072-6694/13/18/4656

Similar Items